| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |